One of the most common misconceptions about drug testing is that every panel automatically includes fentanyl.
In many cases, that’s not true.
Traditional workplace drug testing panels were originally designed to screen for commonly tested substances such as marijuana, cocaine, amphetamines, opiates, and PCP. As drug trends have evolved, testing options have expanded, but fentanyl is not always included by default.
That means two organizations may both use a "10-panel" or "12-panel" test, yet have different panel configurations depending on the products selected and the substances they want to monitor.
This distinction is important because fentanyl is a synthetic opioid. Standard opiate panels are often designed to detect naturally occurring opiates, while fentanyl may require a dedicated test line or an expanded panel configuration depending on the screening device being used.
For employers, treatment programs, healthcare providers, and community organizations, understanding exactly what a test panel covers is an important part of building an effective screening program.
The key takeaway is simple: don't assume fentanyl is included. Review the panel specifications and confirm which substances are actually being tested.
As awareness grows, more organizations are choosing to evaluate whether fentanyl screening aligns with their program goals and workplace environment.
Fact Friday takeaway:
Not all drug tests include fentanyl. Understanding your panel configuration helps ensure your testing program aligns with your organization's objectives.
Using a credible resource for drug screening supplies helps support consistency and reliability across your program.
